CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Cardiac Stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04390841
NCT04390841N/ACompleted
CompareCT.gov

Clinical Trial for Pre-market Registration of Biotronik Qubic Stim Cardiac Stimulator

Biotronik (Beijing) Medical Device Ltd.·interventional·Posted May 18, 2020·Updated Mar 12, 2024

In Brief

A clinical study evaluating Cardiac Stimulator for Arrhythmia. Completed, enrolled 106 participants across 3 sites.

Detailed Summary

106 subjects selected from 3 study sites in China are with indications for intracardiac electrophysiological examination. The trial is to prove the clinical effectiveness and safety of Qubic Stim Cardiac Stimulator in Chinese population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 18, 2020
Enrollment StartDec 1, 2020
Primary CompletionApr 7, 2021
Study CompletionApr 12, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.1 years ago

Interventions

Cardiac Stimulatordevice

The subjects will receive the intracardiac electrophysiological examination, during which the subjects will be subject to diagnostic electrical stimulation by the Qubic Stim Cardiac Stimulator. The subjects will also receive the clinical follow-up visit after cardiac electrical stimulation until they are discharged from the hospital.